Clinical Trials | April 22, 2026
Moderna launches late-stage trial of mRNA bird flu vaccine
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
The collaboration promises expanded funding for Thai universities, research institutes, companies, and global research partners working in Thailand
In his new role, Saran will spearhead the end-to-end launch framework for innovation-led portfolio
COVIRIX Medical says its broad-spectrum antiviral portfolio has already shown positive virology results against key pandemic threats
The facility will manufacture the critical antibiotic intermediate Amino Cephalosporanic Acid (ACA), a key component in the production of cephalosporin antibiotics
The new entity will operate with separate resources, funding, and operations, while BioNTech will contribute related rights and mRNA technologies to support its ambitious mission
One task, one interaction, one pair, experts advocate
Huwel’s diagnostic solutions leverage open RT-PCR system
Subscribe To Our Newsletter & Stay Updated
